STAAR Surgical Company - Common Stock (NQ:STAA)

17.18 -0.40 (-2.28%)

Streaming Delayed Price Updated: 1:07 PM EST, Feb 9, 2026 Add to My Watchlist

Price and Volume

Volume	753,764
Open	17.47
Bid (Size)	17.17 (400)
Ask (Size)	17.18 (200)
Prev. Close	17.58
Today's Range	17.16 - 17.68
52wk Range	13.50 - 30.81
Shares Outstanding	48,333,250
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Cash-Burning Stocks with Open Questions

February 04, 2026

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

Via StockStory

Why STAAR Surgical (STAA) Stock Is Trading Lower Today

February 02, 2026

Shares of medical lens company STAAR Surgical (NASDAQ:STAA) fell 3.5% in the afternoon session after the company announced a leadership transition, appointing interim co-CEOs following the recent...

Via StockStory

Performance

YTD	-27.2%	-27.2%
1 Month	-22.3%	-22.3%
3 Month	-37.3%	-37.3%
6 Month	-37.1%	-37.1%
1 Year	-24.0%	-24.0%

More News

STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

February 02, 2026

From STAAR Surgical Company

Via Business Wire

3 Healthcare Stocks Walking a Fine Line

January 18, 2026

Via StockStory

STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings?

January 15, 2026

Via StockStory

STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

January 15, 2026

From STAAR Surgical Company

Via Business Wire

3 Stocks Under $50 That Fall Short

January 11, 2026

Via StockStory

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

January 06, 2026

Via Chartmill

Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon

January 06, 2026

From Broadwood Partners, L.P.

Via Business Wire

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

January 06, 2026

From STAAR Surgical Company

Via Business Wire

New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82% ↗

December 30, 2025

Via The Motley Fool

3 Low-Volatility Stocks We Keep Off Our Radar

December 28, 2025

Via StockStory

What a $22 Million Bet on STAAR Surgical Signals After Third-Quarter Earnings and a 15% Market Lag ↗

December 23, 2025

Via The Motley Fool

3 Cash-Heavy Stocks We Keep Off Our Radar

December 21, 2025

Via StockStory

Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon

December 19, 2025

From Broadwood Partners, L.P.

Via Business Wire

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

December 19, 2025

From STAAR Surgical Company

Via Business Wire

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

December 17, 2025

From Broadwood Partners, L.P.

Via Business Wire

STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

December 17, 2025

From STAAR Surgical Company

Via Business Wire

Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory

December 16, 2025

From Yunqi Capital Limited

Via Business Wire

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

December 16, 2025

From STAAR Surgical Company

Via Business Wire

Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

December 16, 2025

From Broadwood Partners, L.P.

Via Business Wire

Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

December 15, 2025

From STAAR Surgical Company

Via Business Wire

Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

December 12, 2025

From Broadwood Partners, L.P.

Via Business Wire

Why STAAR Surgical (STAA) Stock Is Up Today

December 11, 2025

Via StockStory

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

December 11, 2025

From STAAR Surgical Company

Via Business Wire

Frequently Asked Questions

Is STAAR Surgical Company - Common Stock publicly traded?

Yes, STAAR Surgical Company - Common Stock is publicly traded.

What exchange does STAAR Surgical Company - Common Stock trade on?

STAAR Surgical Company - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for STAAR Surgical Company - Common Stock?

The ticker symbol for STAAR Surgical Company - Common Stock is STAA on the Nasdaq Stock Market

What is the current price of STAAR Surgical Company - Common Stock?

The current price of STAAR Surgical Company - Common Stock is 17.18

When was STAAR Surgical Company - Common Stock last traded?

The last trade of STAAR Surgical Company - Common Stock was at 02/09/26 01:07 PM ET

What is the market capitalization of STAAR Surgical Company - Common Stock?

The market capitalization of STAAR Surgical Company - Common Stock is 830.37M

How many shares of STAAR Surgical Company - Common Stock are outstanding?

STAAR Surgical Company - Common Stock has 830M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.